We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Portable Molecular POC System Rules Out UTIs in Just 35 Minutes

By LabMedica International staff writers
Posted on 20 Jun 2025

Urinary tract infections (UTIs) represent a massive burden on patients and healthcare systems. More...

There are over 400 million UTI cases globally each year, of which around 90% are in women. Fast and accurate UTI diagnosis is crucial for effective treatment and for preventing complications. The gold standard for UTI diagnosis is still considered to be laboratory culture. This is despite lab culture tests taking at least 24 hours to provide a result because of the need to transport the sample to a lab and the time taken to incubate the sample. Waiting for culture results can lead to delays in determining the best course of action and prescribing inappropriate or unnecessary antibiotics.

The other most common approach to UTI testing is the use of dipsticks. These are cheap to buy and simple to use, but have a maximum sensitivity of around 74%. There is a need for faster, more accurate, and inexpensive UTI diagnostics to improve the way patients are treated and reduce the volume of antibiotic prescriptions issued. Now, a portable diagnostic device that delivers lab-accurate results for UTIs in around half an hour to guide real-time clinical decision-making at the point-of-care.

The Lodestar DX UTI rapid molecular diagnostic platform from Llusern Scientific (Cardiff, UK) is based on isothermal LAMP technology (not PCR) without the need for DNA extraction or centralized lab infrastructure. This low-cost, portable, easy-to-use testing system offers up to 97% accuracy in detecting the presence of clinically relevant levels of UTI-causing bacteria. With industry-leading sensitivity and specificity, Lodestar DX empowers clinicians to diagnose and treat specific microbial infections with precision in a single visit, thereby improving patient outcomes.

As well as providing guidance on the best treatment option based on the specific microbial infection, Lodestar DX also provides a clear ‘rule-out’ decision where antibiotics are not necessary, helping to reduce antimicrobial resistance through antibiotic stewardship. Llusern Scientific has been awarded ISO 13485 certification for its Lodestar DX testing system, marking a crucial regulatory step for marketing its medical device globally.

“Not only does our Lodestar UTI testing system help a clinician decide whether or not to prescribe an antibiotic, but it will also identify the bacterial cause of the UTI,” said co-founder and CEO, Dr. Emma Hayhurst. “This enables clinicians to quickly target the right bug with the right treatment to save lives. Now that we have ISO 13485 certification, our next goal is to achieve IVDR certification to further expand the market potential for our innovative molecular diagnostic globally.”

Related Links:
Llusern Scientific


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Combining rapid diagnostic tests with conventional serology proves to be a useful strategy for diagnosing Chagas disease (Courtesy of Adobe Stock)

Rapid Tests for Chagas Disease Improves Diagnostic Access

Chagas disease, caused by the parasite Trypanosoma cruzi, affects between six and seven million people across the Americas. It is primarily transmitted by insect vectors and remains largely underdiagnosed,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more

Pathology

view channel
Image: A tool uses artificial intelligence and high-resolution imaging to track senescent cells (Courtesy of Adobe Stock)

AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease

Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.